| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4558623 | Journal of Invertebrate Pathology | 2007 | 4 Pages |
Syngenta is seeking commercial registration for VipCot™ cotton, a pyramided transgenic cotton trait that expresses two insecticidal proteins derived from Bacillus thuringiensis Vip3A and Cry1Ab. Both proteins are highly effective against two key cotton pests, Helicoverpa zea cotton bollworm; and Heliothis virescens, tobacco budworm. To investigate the role of VipCot™ cotton in delaying the development of resistance in these pests to transgenic Bt traits, Syngenta has performed studies to determine the dose of proteins expressed in VipCot™ and evaluate the potential for cross-resistance between the component proteins. Following United States Environmental Protection Agency (US EPA) high dose methods 1 and 4, VipCot™ was shown to express a high dose of proteins for H. zea and H. virescens. VipCot™ was also confirmed to express a high dose of proteins for H. zea through US EPA Method 5. Additionally, all the data collected to date verify a lack of cross-resistance between Vip3A and Cry proteins. These two key pieces of information indicate that VipCot™ cotton should be very durable under the currently mandated high dose plus refuge insect resistance management strategy.
